Bone Morphogenetic Protein-7 (BMP-7), also known as osteogenic protein-1 (OP-1), is a member of the transforming growth factor-beta (TGF-β) superfamily. This protein plays a crucial role in the development and repair of bone and cartilage. BMP-7 is encoded by the BMP7 gene in humans and is involved in various biological processes, including embryogenesis, hematopoiesis, neurogenesis, and skeletal morphogenesis .
Human recombinant BMP-7 produced in plants is a monomeric, glycosylated polypeptide chain containing 144 amino acids and has a molecular mass of 16.5 kDa. It is fused to a 6xHis-tag at the N-terminus and is purified using proprietary chromatographic techniques . The recombinant production of BMP-7 in plants offers a cost-effective and scalable method for generating this protein, which is essential for therapeutic applications.
BMP-7 functions by initiating the canonical BMP signaling cascade. It associates with type I receptor ACVR1 and type II receptor ACVR2A at the cell surface. Once all three components are bound together in a complex, ACVR2A phosphorylates and activates ACVR1. This activation propagates the signal by phosphorylating SMAD1/5/8, which then travel to the nucleus and act as activators and repressors of transcription of target genes .
Human recombinant BMP-7 has significant therapeutic potential, particularly in the field of orthopedics. It is a potent bone-inducing agent and can be used in the treatment of bone defects when combined with an appropriate osteoconductive carrier, such as a collagen sponge or synthetic hydroxyapatite . BMP-7 has been used in surgical procedures to promote bone healing and regeneration.